GVAX vs. Placebo for MDS/AML After Allo HSCT

Clinical trial NCT01773395 · TERMINATED

Trial details

NCT number: NCT01773395
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia

Start date: 2013-01-08
Primary completion: 2020-12-11
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.